Aurora Cannabis Advances Auto-Flowering Research
Ticker: ACB · Form: 6-K · Filed: Sep 17, 2024 · CIK: 1683541
| Field | Detail |
|---|---|
| Company | Aurora Cannabis Inc (ACB) |
| Form Type | 6-K |
| Filed Date | Sep 17, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: R&D, cannabis, cultivation
TL;DR
Aurora Cannabis is making strides in auto-flowering tech, potentially boosting cultivation efficiency.
AI Summary
Aurora Cannabis Inc. announced on September 17, 2024, that it has made significant advancements in its auto-flowering research, unveiling key insights into cannabinoid and terpene production. The company's CEO, Miguel Martin, highlighted the potential of this research to drive innovation and efficiency in cannabis cultivation.
Why It Matters
This research could lead to more efficient and cost-effective cannabis cultivation methods, potentially impacting the company's profitability and market position.
Risk Assessment
Risk Level: low — This filing is an informational update on research and development, not a financial event with immediate market-moving implications.
Key Players & Entities
- Aurora Cannabis Inc. (company) — Registrant
- Miguel Martin (person) — CEO of Aurora Cannabis Inc.
- September 17, 2024 (date) — Date of News Release
FAQ
What specific insights has Aurora Cannabis unveiled regarding cannabinoid and terpene production in their auto-flowering research?
The filing states that Aurora Cannabis has unveiled 'key insights' into cannabinoid and terpene production, but does not provide specific details within the provided text.
What is the significance of auto-flowering research for Aurora Cannabis?
The research is expected to drive innovation and efficiency in cannabis cultivation, potentially leading to improved production methods.
Who is Miguel Martin and what is his role at Aurora Cannabis?
Miguel Martin is the Chief Executive Officer (CEO) of Aurora Cannabis Inc.
What type of report is this 6-K filing?
This is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What exhibits are included with this 6-K filing?
The filing includes Exhibit 99.1, a News Release dated September 17, 2024.
Filing Stats: 144 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2024-09-17 07:19:40
Filing Documents
- aurora_6k.htm (6-K) — 7KB
- ex991.htm (EX-99.1) — 12KB
- logo.jpg (GRAPHIC) — 11KB
- 0001279569-24-001129.txt ( ) — 35KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F Form 40-F SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated September 17, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: September 17, 2024